Abstract
AbstractThis study presents an in‐depth inquiry into estimating ADME properties for promising anticancer drugs, particularly amino acid‐based alkylating agents, through ev‐ve degree topological indices and QSPR analysis. The aim of the study is to compare multigraph modeling to simple graph modeling in estimating six ADME properties. Results demonstrate that multigraph modeling's superior performance, with notable high correlations such as for maximum passive absorption (MPA) using the M‐ev index, compared to simple graph modeling's with the ‐ev index. This emphasizes the need for sophisticated modeling techniques in drug development. The primary objective is to compare multigraph and simple graph modeling using topological structure descriptors, followed by QSPR analysis to determine the better approach in estimating ADME properties. MCDM weight allocation techniques validate correlation values, enhancing understanding of estimators and identifying potential drugs. This underscores the importance of considering various MCDM methods and weight allocation approaches for reliable decision‐making in healthcare contexts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
